What can we learn from the recent blood glucose lowering megatrials?

od Chan, Juliana CN
Izdano 2011

Risk‐benefit analysis of use of statins for primary prevention of cardiovascular disease in subjects without diabetes

od Chan, Juliana CN
Izdano 2013

Metformin and the risk of cancer in type 2 diabetes: methodological challenges and perspectives

od Yang, Xilin, Chan, Juliana CN
Izdano 2014

Comment: Analyses Using Time-Dependent Pioglitazone Usage in Cox Models May Lead to Wrong Conclusions About Its Association With Cancer

od Yang, Xilin, Chan, Juliana C.N.
Izdano 2011

Diabetes, insulin and cancer risk

od Yang, Xi-Lin, Chan, Juliana CN
Izdano 2012

Comment on: Suissa and Azoulay. Metformin and the Risk of Cancer: Time-Related Biases in Observational Studies. Diabetes Care 2012;35:2665–2673

od Yang, Xilin, Chan, Juliana C.N.
Izdano 2013

Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States

od Ma, Ronald CW, Chan, Juliana CN
Izdano 2013

Evidence for DNA Damage as a Biological Link Between Diabetes and Cancer

od Lee, Shao Chin, Chan, Juliana CN
izdano v Chin Med J (Engl) (2015)

Biologics and biosimilars: what, why and how?

od Chan, Juliana CN, Chan, Anthony TC
izdano v ESMO Open (2017)

pH-responsive Nanoparticles for Drug Delivery

od Gao, Weiwei, Chan, Juliana, Farokhzad, Omid C.
Izdano 2010

Early Identification of Type 2 Diabetes: Policy should be aligned with health systems strengthening

od Narayan, K.M. Venkat, Chan, Juliana, Mohan, Viswanathan
Izdano 2011

Diabetes: A Cinderella Subject We Can’t Afford to Ignore

od Chan, Juliana C. N., Luk, Andrea O. Y.
izdano v PLoS Med (2016)

Precision medicine in diabetes prevention, classification and management

od Xie, Fangying, Chan, Juliana CN, Ma, Ronald CW
izdano v J Diabetes Investig (2018)

Metabolic Syndrome and Type 2 Diabetes: The Hong Kong Perspective

od Chan, Norman N, Kong, Alice PS, Chan, Juliana CN
Izdano 2005

Methodological challenges to control for immortal time bias in addressing drug effects in type 2 diabetes

od Yang, Xi-Lin, Huo, Xiao-Xu, Chan, Juliana CN
izdano v World J Methodol (2015)

Prevention and Care Programs Addressing the Growing Prevalence of Diabetes in China

od Yin, Junmei, Kong, Alice P. S., Chan, Juliana C. N.
izdano v Curr Diab Rep (2016)

Exendin-4 Improves Blood Glucose Control in Both Young and Aging Normal Non-Diabetic Mice, Possible Contribution of Beta Cell Independent Effects

od Fan, Rongrong, Kang, Zhanfang, He, Lan, Chan, Juliana, Xu, Gang
Izdano 2011

Efficacy and Safety of Linagliptin in 2681 Asian Patients Stratified by Age, Obesity, and Renal Function: A Pooled Analysis of Randomized Clinical Trials

od Ning, Guang, Bandgar, Tushar, Hehnke, Uwe, Lee, Jisoo, Chan, Juliana C. N.
izdano v Adv Ther (2017)

Microengineering in cardiovascular research: new developments and translational applications

od Chan, Juliana M., Wong, Keith H.K., Richards, Arthur Mark, Drum, Chester L.
izdano v Cardiovasc Res (2015)

Safety of atorvastatin in Asian patients within clinical trials

od Chan, Juliana C. N., Kong, Alice P. S., Bao, Weihang, Fayyad, Rana, Laskey, Rachel
izdano v Cardiovasc Ther (2016)